Moderna says RSV vaccine FDA approval delayed to end of May
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end …
Pfizer Inc
Novavax and Sanofi to commercialize Covid vaccine, develop combo shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. …
Pfizer (PFE) earnings Q1 2024
Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefitting from its broad cost-cutting program and strong …
Eli Lilly (LLY) says it can overcome high-quality problem of too much demand
Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly …
Fed meeting and Apple, Amazon, Eli Lilly report
CNBC’s Jim Cramer on Friday walked investors through next week on Wall Street. It’s a week jam-packed with notable events, including earnings from Apple, Amazon and Eli Lilly. He also …
FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B
Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy …
Bristol Myers Squibb (BMY) earnings Q1 2024
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb …
Merck (MRK) earnings Q1 2024
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings …
Pfizer RSV vaccine may protect high-risk adults ages 18-59
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are …
Moderna says new Covid vaccine showed positive late-stage data
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger …